Skip Navigation

Evidence-Based Toxicology Collaboration

EBTC Session at EUROTOX 2013 September 1-4, 2013, Switzerland

September 1-4, 2013
Interlaken, Switzerland

EUROTOX 2013 included an Evidence-based Toxicology Collaboration session.

Evidence-based approaches, which were pioneered in medicine, provide the means to transparently, objectively, and consistently assess the evidence bearing on questions in medicine or other fields of science. The Evidence-based Toxicology Collaboration (EBTC) was formed to translate the principles and approaches of Evidence-based Medicine/Health Care to toxicology. The EBTC comprises stakeholders in academia, industry, and government seeking to strengthen decision-making in safety sciences, and thereby enhance confidence in the process by which scientific evidence is assessed. The EBTC is primarily interested in assessing the performance of the toxicological test methods and addressing questions about the safety of substances to human health and the environment. The EBTC’s efforts are timely, as there is growing interest in applying systematic reviews in toxicology, which would be facilitated by a toxicology ontology, be as well as a growing recognition that new test assessment approaches are needed, for example in the context of composing and assessing integrated testing strategies.

The EUROTOX meeting offered a unique opportunity for toxicologists with different backgrounds, coming from a variety of countries, to meet and network with friends, colleagues and leaders in the different disciplines.

See EUROTOX 2013’s webpage for more information.

Agenda for the Evidence-based Toxicology Session at EUROTOX 2013

September 1, 2013

13:00 – 14:00
Evidence-based Toxicology
Chair: Thomas Hartung, USA
Room: Grimsel 1+2

13:00 – 13:20
Evidence-based Toxicology (EBT) and the EBT Collaboration
Sebastian Hoffmann, Germany

13:20 – 13:40
EBT and Integrated Testing Strategy
Thomas Hartung, USA

13:40 – 14:00
Toxicology Ontology Development supporting Evidence-based Approaches in Predictive Toxicology
Barry Hardy, Switzerland